ACES Diagnostics, Inc. has announced a new private offering of securities, aiming to raise up to $8.7 million. This significant move is part of the company’s strategy to enhance its operations and expand its market presence.

The filing, submitted on October 27, 2026, reveals that ACES Diagnostics is offering Series A-1, A-2, and A-3 Preferred Stock. The company has already sold approximately $7 million of the total offering amount, indicating a strong interest from investors.

Background

ACES Diagnostics, Inc. is a corporation incorporated in Delaware, with its business address located at 4949 E Lincoln Dr., #5, Paradise Valley, AZ. The company operates in the diagnostics sector and has a fiscal year ending on December 31. Its recent filings include a Form D submitted on October 27, 2026, and another on June 25, 2026.

What the Filing Says

The SEC filing states, “Rule 506(b) provides a 'safer harbor' for a private offering.” This indicates that the company is utilizing a regulatory framework designed to facilitate private fundraising.

Impact

The offering may significantly affect the company’s financial position and operational capabilities. With 30 investors already committed, ACES Diagnostics is poised to leverage this capital for growth initiatives. The filing does not specify any direct competitors, but the move positions ACES Diagnostics favorably within the diagnostics industry.

What's Next

The filing does not say what happens next.